Two of these patients were treated with sofosbuvir and underwent transplantation because of chronic active hepatitis C. Data in the literature suggests that RANTES levels are significantly higher in chronic active hepatitis C subjects.28 Two other patients were treated with blinatumomab before conditioning, because of relapsed leukemia. The gene discussed is CCL5; the disease is leukemia.